Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
GMO Pepabo, Jan-Mar (1Q) Ordinary Profit Decreases by 13%
3633 GMO Pepabo, Inc. 【J-GAAP】
Earnings ReportGMO Pepabo, Inc. <3633> [TSE Std] announced its financial results after the market closed on May 14th (15:31). The consolidated ordinary profit for the first quarter of the fiscal year ending December 2026 (January to March) decreased 13.3% from the same period last year to 0.26 billion yen. However, Progress toward the full-year plan of 1.05 billion yen was 25.5%, almost the same as the five-year average (Excluding loss-making periods) of 26.3%.
In the most recent three-month period, from January to March (1Q), the operating profit margin decreased from 12.2% in the same period last year to 9.8%.
Kabutan News
Actual Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Progress Rate vs. First Half | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Jan - Mar, 2024 | 2,647 | 234 | 235 | 154 | 29.3 | 47.7 | May 8, 2024 | J-GAAP |
| Jan - Mar, 2025 | 2,745 | 335 | 309 | 237 | 45.0 | 55.3 | May 13, 2025 | J-GAAP |
| Jan - Mar, 2026 | 2,614 | 255 | 268 | 188 | 36.5 | ー | May 14, 2026 | J-GAAP |
| YoY | -4.8% | -23.9% | -13.3% | -20.7% | -18.8% |
Current Period Guidance
H1 Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Jan - Jun, 2025 | 5,539 | 597 | 559 | 397 | 75.8 | 0 | Aug 7, 2025 | J-GAAP |
| Jan - Jun, 2026 Guidance | ー | ー | ー | ー | - | 0 | Feb 10, 2026 | J-GAAP |
| YoY | - | - | - | - | - |
Current Period Guidance
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Dec, 2024 | 10,922 | 829 | 937 | 591 | 112.1 | 57 | Feb 5, 2025 | J-GAAP |
| Dec, 2025 | 10,959 | 932 | 1,229 | 878 | 168.7 | 111 | Feb 10, 2026 | J-GAAP |
| Dec, 2026 Guidance | 11,000 | 1,050 | 1,050 | 735 | 142.5 | 93 | Feb 10, 2026 | J-GAAP |
| YoY | +0.4% | +12.7% | -14.6% | -16.3% | -15.5% |
Quarterly Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Operating Profit Margin | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Jan - Mar, 2025 | 2,745 | 335 | 309 | 237 | 45.0 | 12.2 | May 13, 2025 | J-GAAP |
| Apr - Jun, 2025 | 2,794 | 262 | 250 | 160 | 30.6 | 9.4 | Aug 7, 2025 | J-GAAP |
| Jul - Sep, 2025 | 2,724 | 193 | 487 | 362 | 69.3 | 7.1 | Nov 12, 2025 | J-GAAP |
| Oct - Dec, 2025 | 2,696 | 142 | 183 | 119 | 22.9 | 5.3 | Feb 10, 2026 | J-GAAP |
| Jan - Mar, 2026 | 2,614 | 255 | 268 | 188 | 36.5 | 9.8 | May 14, 2026 | J-GAAP |
| YoY | -4.8% | -23.9% | -13.3% | -20.7% | -18.8% |
Related Articles
Future Innovation Group, Jan-Mar (1Q) Ordinary Profit Increases by 64%
BrightPath Biotherapeutics, The Current Fiscal Year's Net Income to Widen
GMO TECH, Jan-Mar (1Q) Ordinary Profit 135 Million Yen
Dynamic Map, Last Fiscal Year's Ordinary Profit Loss Widens, Current period performance is undisclosed.
eWeLL, Jan-Mar (1Q) Ordinary Profit Increases by 15%
GMO GlobalSign, Jan-Mar (1Q) Ordinary Profit Increases by 63%
VELTRA, Jan-Mar (1Q) Net Income Turns to Loss
GMO Media, Jan-Mar (1Q) Ordinary Profit Decreases by 40%
GMO Commerce, Jan-Mar (1Q) Ordinary Profit 158 Million Yen
PRONI, Jan-Mar (1Q) Ordinary Profit 154 Million Yen